skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: 1] Opsens Inc XTSE: OPS $2.23 CAD▲ +0.05 (+2.29%) today

2] OpSens Inc.

Short Description: Treasury Offering of Common Shares

Price: $1.90 CND per share.

Settlement: December 22, 2022.

Are 1 & 2 the same?

What does it do exactly? How do I buy it at $1.90? Is it worth buying?

Thank you.
Read Answer Asked by Ross on December 02, 2022
Q: Thanks for your useful answer. My info is that while legalization of pot in the US is not on the cards for the moment, a bill called the Safe Banking Act (in the US) is expected to pass in 2023 whose passage will allow institutional participation in the sector, which is something they cannot presently do, and a surge in purchases with significant associated price rises is anticipated as a result. This is some way out in front but the markets anticipate and I wondered how much of a hill Canopy for example had to climb, here or in the US.
Read Answer Asked by Mike on December 01, 2022
Q: Is there something to replace WELL in the Healthcare sector in Canada or US, ETF inclued?
Read Answer Asked by Yves on November 28, 2022
Q: Good Day All,

You recently answered a question on this company from another subscriber, and mentioned something about the cannabis sector. The way the answer was structured leaves me wondering about this remark as I don't believe CRRX operates in that sector; rather it provides drugs to seniors. Is the review of the fundamentals correct for the company, or are your comments based upon a different company in the cannabis sector? Could you clarify?
Read Answer Asked by Robert on November 25, 2022
Q: VRNA Your opinion of this co. as a new investment?
Read Answer Asked by Lesley on November 25, 2022
Q: Time to move on? Bought to target medical equipment at a reasonable valuation. Have full positions in ABBV and MRK and VHT for health care. Bought MDT thinking it would do well when medical procedures came back after coved. It was hit on diabetes and now earnings projections. Loosing patience. It is about the same price as 10 yrs ago. Im a value investor and like the dividend but need some growth. Suggestions.
Read Answer Asked by Peter on November 23, 2022
Q: Could I please your breakdown of RX recent earning report. Also, would you recommend Buy, Sell or Hold. Thanks … Cal
Read Answer Asked by cal on November 22, 2022
Q: I hold these 3 healthcare stocks. Thinking of adding Lily. Do you see too much overlap in this combination or can you recommend others for diversification?

Thanks very much.

Mike
Read Answer Asked by Michael on November 21, 2022
Q: Hello Peter,

We do not own LNTH as of yet but are watching the stock. When looking at sales and stock price for a 5-year period it was relatively flat. What event triggered a 3-fold increase in stock price? Was it one very large order for equipment in 2021 or a sustainable increase in equipment sales?

Cheers,
Debbie and Jerry
Read Answer Asked by Jerry on November 21, 2022
Q: I just sold off my Biogen holding and am looking for a replacement within the healthcare sector. I held Biogen for over 3 years and exited with a nice return, but I have to say that I did not enjoy the wild ride and price swings as it seemed to trade solely on its new Alzheimer’s drug advancements and setbacks. So now I am looking to replace it with something a little more stable but still with the expectation of slow and steady growth. What would be your top 1 or 2 picks be today for both the US and Canada that might fit. I already own Savaria and XLV so something besides these.
Read Answer Asked by Steven on November 18, 2022